tiprankstipranks
Advertisement
Advertisement
Femasys advances FemBloc to U.S. approval with initiation of trial enrollment
PremiumThe FlyFemasys advances FemBloc to U.S. approval with initiation of trial enrollment
1M ago
Femasys initiated with a Buy at Lake Street
Premium
The Fly
Femasys initiated with a Buy at Lake Street
1M ago
Femasys’s FemBloc Pivotal Trial Update: What Investors Should Watch in Women’s Health
Premium
Company Announcements
Femasys’s FemBloc Pivotal Trial Update: What Investors Should Watch in Women’s Health
1M ago
Femasys granted 180-day extension by Nasdaq to regain compliance
PremiumThe FlyFemasys granted 180-day extension by Nasdaq to regain compliance
3M ago
Femasys announces partnership with Refuah Health Center
Premium
The Fly
Femasys announces partnership with Refuah Health Center
3M ago
Femasys files to sell 68.42M shares of common stock for holders
Premium
The Fly
Femasys files to sell 68.42M shares of common stock for holders
3M ago
Femasys initiated with a Buy at Laidlaw
PremiumThe FlyFemasys initiated with a Buy at Laidlaw
5M ago
Femasys: Strategic Advancements and Financial Health Justify Buy Rating
Premium
Ratings
Femasys: Strategic Advancements and Financial Health Justify Buy Rating
5M ago
Femasys Secures Major Order for FemBloc Launch
Premium
Company Announcements
Femasys Secures Major Order for FemBloc Launch
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100